Suppr超能文献

肾功能评估方程:一篇叙述性综述。

Kidney function estimation equations: a narrative review.

作者信息

Khader Nisha Abdul, Kamath Veena Ganesh, Kamath Shobha Ullas, Rao Indu Ramachandra, Prabhu Attur Ravindra

机构信息

Department of Nephrology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Department of Community Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

出版信息

Ir J Med Sci. 2025 Apr;194(2):725-743. doi: 10.1007/s11845-025-03874-y. Epub 2025 Jan 28.

Abstract

Glomerular filtration rate (GFR) as a marker of kidney function is important in health and disease management because decreased kidney function is associated with all-cause and cardiovascular mortality, progression of kidney disease, predisposition to acute kidney injury (AKI), and for drug dosage modification. While measured glomerular filtration rate (mGFR) is acknowledged as the most accurate method for evaluating kidney function, it is at present not feasible to be applied in the clinical arena. Estimated glomerular filtration rate (eGFR) is preferred due to its convenience, cost-effectiveness, and seamless integration into standard clinical practice for kidney function evaluation. The presence of multiple equations for eGFR with applications to differing populations makes their use challenging for clinicians. We reviewed available estimated glomerular filtration rate (GFR) equations and their application in different clinical settings both in normal and chronic kidney disease (CKD) patients. These formulae incorporate serum creatinine and/or serum cystatin C levels and correlate them with measured kidney function. Among the many available equations, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is the most recommended due to its robustness and accuracy across diverse patient populations. Strengths and limitations of different eGFR equations are discussed emphasizing the importance of selecting the appropriate equation based on specific patient demographics and clinical scenarios. There is need for regional validation studies to ensure the global applicability of these equations, considering the variations in population characteristics.

摘要

肾小球滤过率(GFR)作为肾功能的一项指标,在健康和疾病管理中至关重要,因为肾功能下降与全因死亡率和心血管死亡率、肾脏疾病进展、急性肾损伤(AKI)易感性以及药物剂量调整相关。虽然测定的肾小球滤过率(mGFR)被认为是评估肾功能最准确的方法,但目前在临床领域应用并不可行。估计肾小球滤过率(eGFR)因其便利性、成本效益以及能无缝融入评估肾功能的标准临床实践而更受青睐。存在多个适用于不同人群的eGFR方程,这使得临床医生在使用时面临挑战。我们回顾了现有的估计肾小球滤过率(GFR)方程及其在正常和慢性肾脏病(CKD)患者不同临床环境中的应用。这些公式纳入血清肌酐和/或血清胱抑素C水平,并将它们与测定的肾功能相关联。在众多可用方程中,慢性肾脏病流行病学协作组(CKD - EPI)方程因在不同患者群体中的稳健性和准确性而最受推荐。讨论了不同eGFR方程的优缺点,强调了根据特定患者人口统计学特征和临床情况选择合适方程的重要性。考虑到人群特征的差异,需要进行区域验证研究以确保这些方程的全球适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f595/12031902/1c7ed503d39a/11845_2025_3874_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验